These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 6121011)
21. Model of central chemical 'serotoninectomy' in mice. Herman ZS; Bonczek A Pharmacology; 1978; 17(1):8-14. PubMed ID: 684075 [TBL] [Abstract][Full Text] [Related]
22. Effects of neonatal treatment with 5,7-dihydroxytryptamine or 6-hydroxydopamine on the ontogenetic development of the audiogenic immobility reaction in the rat. Hard E; Ahlenius S; Engel J Psychopharmacology (Berl); 1983; 80(3):269-74. PubMed ID: 6412273 [TBL] [Abstract][Full Text] [Related]
23. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease. Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269 [TBL] [Abstract][Full Text] [Related]
24. Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions. Olds ME; Jacques DB; Kopyov O Synapse; 2006 Jun; 59(8):532-44. PubMed ID: 16565974 [TBL] [Abstract][Full Text] [Related]
25. Striatal dopamine depletion, tremors, and hypokinesia following the intracranial injection of S-adenosylmethionine: a possible role of hypermethylation in parkinsonism. Charlton CG; Crowell B Mol Chem Neuropathol; 1995 Dec; 26(3):269-84. PubMed ID: 8748929 [TBL] [Abstract][Full Text] [Related]
26. Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-L-carnitine. Sarkar S; Gough B; Raymick J; Beaudoin MA; Ali SF; Virmani A; Binienda ZK Neurosci Lett; 2015 Oct; 606():53-9. PubMed ID: 26321151 [TBL] [Abstract][Full Text] [Related]
27. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid. Steranka LR Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818 [TBL] [Abstract][Full Text] [Related]
28. The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey. Irwin I; DeLanney LE; Forno LS; Finnegan KT; Di Monte DA; Langston JW Brain Res; 1990 Oct; 531(1-2):242-52. PubMed ID: 1981162 [TBL] [Abstract][Full Text] [Related]
29. (-)-Sulpiride activates the firing rate and tyrosine hydroxylase activity of dopaminergic neurons in unanesthetized rats. Mereu G; Casu M; Gessa GL Brain Res; 1983 Mar; 264(1):105-10. PubMed ID: 6133578 [TBL] [Abstract][Full Text] [Related]
30. The ontogeny of amphetamine-induced dopamine release in the caudate-putamen of the rat. Gazzara RA; Fisher RS; Howard SG Brain Res; 1986 Aug; 393(2):213-20. PubMed ID: 3742239 [TBL] [Abstract][Full Text] [Related]
31. Sequential course of uptake of intravitreal 5,7-dihydroxytryptamine by carp retinal cells. Negishi K; Teranishi T Brain Res; 1990 Jan; 508(1):135-41. PubMed ID: 1970941 [TBL] [Abstract][Full Text] [Related]
32. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions. Kääriäinen TM; García-Horsman JA; Piltonen M; Huotari M; Männistö PT Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):300-7. PubMed ID: 17973898 [TBL] [Abstract][Full Text] [Related]
33. The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. Hotchkiss AJ; Morgan ME; Gibb JW Life Sci; 1979 Oct; 25(16):1373-8. PubMed ID: 42834 [No Abstract] [Full Text] [Related]
34. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712 [TBL] [Abstract][Full Text] [Related]
35. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine. Breese GR; Vogel RA; Mueller RA J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057 [TBL] [Abstract][Full Text] [Related]
36. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals. Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521 [TBL] [Abstract][Full Text] [Related]
38. Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism. Kozina EA; Khakimova GR; Khaindrava VG; Kucheryanu VG; Vorobyeva NE; Krasnov AN; Georgieva SG; Kerkerian-Le Goff L; Ugrumov MV J Neurol Sci; 2014 May; 340(1-2):198-207. PubMed ID: 24768159 [TBL] [Abstract][Full Text] [Related]
39. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems. Johnson M; Elayan I; Hanson GR; Foltz RL; Gibb JW; Lim HK J Pharmacol Exp Ther; 1992 May; 261(2):447-53. PubMed ID: 1349640 [TBL] [Abstract][Full Text] [Related]
40. Effects of neonatal administration of 5,7-dihydroxytryptamine on locomotor activity. Lucot JB; Seiden LS Psychopharmacology (Berl); 1982; 77(2):114-6. PubMed ID: 6812128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]